iSpecimen to Report Second Quarter 2021 Results on August 10, 2021

Rhea-AI Summary

iSpecimen Inc. (Nasdaq: ISPC) will report its financial results for the second quarter ending June 30, 2021, before market open on August 10, 2021. A conference call and audio webcast will take place at 8:30 a.m. Eastern Time the same day, featuring remarks from CEO Christopher Ianelli, CFO Tracy Curley, and COO Jill Mullan. Those unable to attend can access a replay until August 24, 2021. iSpecimen operates an online marketplace for human biospecimens, connecting researchers with healthcare providers.

LEXINGTON, Mass., July 27, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will report its financial results for the second quarter ended June 30, 2021, before the market open on Tuesday, August 10, 2021.

The Company will host a conference call and audio webcast that morning at 8:30 a.m. Eastern Time featuring remarks by Christopher Ianelli, MD, PhD, CEO and President, Tracy Curley, CFO, and Jill Mullan, COO.

Event:	iSpecimen Second Quarter 2021 Results Conference Call
Date:	Tuesday, August 10, 2021
Time:	8:30 a.m. Eastern Time
Live Call:	+1-877-425-9470 (Toll Free) or + 1-201-389-0878 (International)
Webcast:	http://public.viavid.com/index.php?id=1457777http://public.viavid.com/index.php?id=145777

For interested individuals unable to join the conference call, a replay will be available through August 24, 2021, at +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 13721607. An archived version of the webcast will also be available on iSpecimen's Investor Relations site: https://ispecimen.irpass.com/.

About iSpecimen
iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. For more information about iSpecimen, please visit www.ispecimen.com.

Forward Looking Statements
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," believe," "estimate" and "continue" or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information.

Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risks factors contained in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. Forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time, and it is not possible for the Company to predict those events or how they may affect the Company. If a change to the events and circumstances reflected in the Company's forward-looking statements occurs, the Company's business, financial condition and operating results may vary materially from those expressed in the Company's forward-looking statements.

Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

For further information, please contact:

Investor Contact
KCSA Strategic Communications
Allison Soss / Scott Eckstein
iSpecimen@kcsa.com

Media Contact
Kaitlynn Cooney
For iSpecimen
kcooney@brodeur.com 
617.587.2811

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ispecimen-to-report-second-quarter-2021-results-on-august-10-2021-301341635.html

SOURCE iSpecimen Inc.

FAQ

What date will iSpecimen report its second quarter 2021 results?

iSpecimen will report its second quarter 2021 results on August 10, 2021.

What time is the iSpecimen second quarter 2021 results conference call?

The conference call for iSpecimen's second quarter 2021 results is scheduled for 8:30 a.m. Eastern Time on August 10, 2021.

Who will be speaking during the iSpecimen conference call?

CEO Christopher Ianelli, CFO Tracy Curley, and COO Jill Mullan will speak during the iSpecimen conference call.

How can I listen to the iSpecimen conference call?

The iSpecimen conference call can be accessed via phone at +1-877-425-9470 or through a webcast available on their Investor Relations site.

What is the purpose of iSpecimen's marketplace?

iSpecimen offers a marketplace that connects researchers with healthcare providers for human biospecimens needed for medical research.